Alpha Tau Medical (XTAE:DRTS) EV-to-FCF: (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:DRTS Alpha Tau Medical Ltd XTAE:DRTS
6 GF Score
Price ₪44.01
! 3 Warning Signs
View Full Analysis

What is Alpha Tau Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alpha Tau Medical's Enterprise Value is ₪3,764.26 Mil. Alpha Tau Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₪0.00 Mil. Therefore, Alpha Tau Medical's EV-to-FCF for today is .

The historical rank and industry rank for Alpha Tau Medical's EV-to-FCF or its related term are showing as below:

XTAE:DRTS' s EV-to-FCF Range Over the Past 10 Years
Min: -38.33   Med: 0   Max: 0
Current: -38.33

XTAE:DRTS's EV-to-FCF is ranked worse than
100% of 332 companies
in the Biotechnology industry
Industry Median: 16.745 vs XTAE:DRTS: -38.33

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-14), Alpha Tau Medical's stock price is ₪44.01. Alpha Tau Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₪-3.066. Therefore, Alpha Tau Medical's PE Ratio (TTM) for today is At Loss.


Alpha Tau Medical  (XTAE:DRTS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Alpha Tau Medical's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=44.01/-3.066
=At Loss

Alpha Tau Medical's share price for today is ₪44.01.
Alpha Tau Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-3.066.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Alpha Tau Medical EV-to-FCF Related Terms


Alpha Tau Medical EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Alpha Tau Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Tau Medical EV-to-FCF Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial 0.00 -4.86 -5.80 -7.77 -11.49

Alpha Tau Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -11.49 0.00 0.00

XTAE:DRTS vs : EV-to-FCF Comparison

For the Biotechnology subindustry, Alpha Tau Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's EV-to-FCF falls into.


XTAE:DRTS
6GF Score
Alpha Tau Medical Ltd XTAE:DRTS
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Tau Medical EV-to-FCF Calculation

Alpha Tau Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3764.255/0
=

Alpha Tau Medical's current Enterprise Value is ₪3,764.26 Mil.
Alpha Tau Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical Business Description

Comparable Companies
Other Exchanges DRTS:USA
Address Kiryat HaMada Street 5, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
6GF Score

Get the complete analysis for XTAE:DRTS

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪44.01
Price